Sean McAuliffe

Sean McAuliffe serves as Chief Business Officer at Taysha Gene Therapies. Taysha Gene Therapies operates in the biotechnology sector with approximately 120.0 employees. The company is headquartered in Vernon Hills, Illinois. Taysha Gene Therapies generates annual revenue of 6710000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at Taysha Gene Therapies.
• • 3,772 executive contacts are available in Illinois.
• • Our database includes 201,469 c suite-level executives.

Outlook MailChimp SPF CloudFlare Hosting Adobe Marketing Cloud Mobile Friendly WordPress.org reCAPTCHA Google Font API Google Tag Manager Google Analytics New Relic Remote AI

gene therapy central nervous system molecular biology biotechnology: biological products (no diagnostic substances) health care monogenic diseases cns diseases rett syndrome tsha-102 gene replacement therapy adeno-associated virus aav9 clinical trials patient-first approach genetic medicine therapy delivery biodistribution intrathecal delivery gene transfer microrna mirare technology orphan drug designation fda approval patient advocacy community support scientific publications disease-modifying therapies genetic disorders therapeutic candidates patient families clinical development rare diseases collaboration transparency therapeutic strategies neurodevelopmental disorders safety assessment efficacy evaluation disease progression stakeholder engagement research & development healthcare professionals investigational therapies expanded access policy disease mechanisms genetic code gene expression levels treatment protocols patient outcomes bioethical standards clinical research cure advocacy patient-centric solutions aav-based therapies gene replacement therapies clinical-stage biotechnology transformative medicines rare genetic disorders healthcare providers research institutions pediatric patients adult patients innovative treatments unmet medical needs biotechnology industry partnerships collaborations neurodegenerative disorders genetic therapies patient demographics therapeutic pipeline health wellness & fitness hospital & health care

FP

Frederick Porter Chief Technical Officer at Taysha Gene Therapies

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Sean McAuliffe, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

How do I reach Sean McAuliffe directly?

Sean McAuliffe's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at Taysha Gene Therapies. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Sean McAuliffe work for?

Sean McAuliffe is Chief Business Officer at Taysha Gene Therapies, a company in the biotechnology sector with 120.0 employees. The company is based in Vernon Hills, Illinois.

Can I pitch or sell to Sean McAuliffe?

As Chief Business Officer at Taysha Gene Therapies, Sean McAuliffe is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Sean McAuliffe directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Sean McAuliffe in?

Sean McAuliffe works in the biotechnology industry as Chief Business Officer at Taysha Gene Therapies. MessageCEO provides verified contact information for executives across all major industries.

Is Sean McAuliffe's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Sean McAuliffe's profile is kept up-to-date with the latest available information.

Last updated: May 13, 2026